Aytu Biopharma, Inc.
AYTU
$2.18
$0.010.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.82M | 3.99M | 788.00K | 1.47M | -4.62M |
| Total Depreciation and Amortization | 1.29M | 1.32M | 1.34M | 1.43M | 1.56M |
| Total Amortization of Deferred Charges | 26.00K | 27.00K | 28.00K | 27.00K | 134.00K |
| Total Other Non-Cash Items | 19.60M | -1.63M | -2.51M | -3.32M | 3.57M |
| Change in Net Operating Assets | 1.70M | -10.16M | 3.26M | -794.00K | -1.44M |
| Cash from Operations | 2.80M | -6.46M | 2.91M | -1.19M | -788.00K |
| Capital Expenditure | -17.00K | -69.00K | -6.00K | -136.00K | -329.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 151.00K | 517.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.00M | -- | -- | -- | 295.00K |
| Cash from Investing | -3.02M | -69.00K | 145.00K | 381.00K | -34.00K |
| Total Debt Issued | 892.00K | 6.02M | -258.00K | 1.88M | 13.81M |
| Total Debt Repaid | -464.00K | -464.00K | -465.00K | -464.00K | -15.65M |
| Issuance of Common Stock | 14.84M | -- | -- | -- | 3.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.28M | -1.25M | -2.04M | -500.00K | -475.00K |
| Cash from Financing | 12.99M | 4.30M | -2.76M | 911.00K | 1.07M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.78M | -2.23M | 290.00K | 102.00K | 246.00K |